The SUBITO trial, presented by Rianne L Seefat and colleagues in The Lancet Oncology,1 revisits the long-standing debate ...
RNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results